Hantech Bio-Technology Co., Ltd. (TPEX:1294)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
80.00
-0.50 (-0.62%)
Feb 11, 2026, 1:30 PM CST

Hantech Bio-Technology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
717.85748.42625.14302.52240.29266.69
Revenue Growth (YoY)
-9.79%19.72%106.65%25.90%-9.90%130.17%
Cost of Revenue
448.95442.68344.29175.89139.27140.36
Gross Profit
268.9305.74280.85126.63101.03126.33
Selling, General & Admin
94.4598.1788.3461.1155.5147.99
Research & Development
11.1610.137.378.096.95.37
Operating Expenses
105.61108.2895.1569.861.3653.68
Operating Income
163.29197.47185.7156.8439.6772.65
Interest Expense
-3.03-5.38-2.12-1.47-1.55-1.02
Interest & Investment Income
2.251.390.650.270.050.03
Currency Exchange Gain (Loss)
0.450.55-0.032.57-0.2-0.41
Other Non Operating Income (Expenses)
0.230.960.460.070.45-0.18
EBT Excluding Unusual Items
163.19194.99184.6858.2838.4271.07
Gain (Loss) on Sale of Assets
--0.35-0.11-0.55-0-1.1
Pretax Income
163.19194.64184.5757.7338.4269.97
Income Tax Expense
30.8139.2237.0411.877.3314.31
Earnings From Continuing Operations
132.38155.42147.5345.8631.0955.66
Minority Interest in Earnings
0.040.260.591.611.470.11
Net Income
132.42155.67148.1247.4732.5655.77
Net Income to Common
132.42155.67148.1247.4732.5655.77
Net Income Growth
-25.19%5.10%212.00%45.81%-41.62%601.65%
Shares Outstanding (Basic)
302828262322
Shares Outstanding (Diluted)
312928262424
Shares Change (YoY)
7.18%3.38%8.45%7.98%2.60%9.89%
EPS (Basic)
4.385.475.361.861.412.49
EPS (Diluted)
4.325.325.231.821.352.37
EPS Growth
-30.09%1.74%188.00%34.69%-43.04%540.52%
Free Cash Flow
162.43126.13-102.03-19.7-34.877.23
Free Cash Flow Per Share
5.294.31-3.60-0.76-1.440.31
Dividend Per Share
2.9072.9070.6990.608-0.349
Dividend Growth
315.99%315.99%14.99%--99.94%
Gross Margin
37.46%40.85%44.93%41.86%42.04%47.37%
Operating Margin
22.75%26.38%29.71%18.79%16.51%27.24%
Profit Margin
18.45%20.80%23.69%15.69%13.55%20.91%
Free Cash Flow Margin
22.63%16.85%-16.32%-6.51%-14.51%2.71%
EBITDA
190.33221.24198.2768.5450.9682.35
EBITDA Margin
26.51%29.56%31.72%22.66%21.21%30.88%
D&A For EBITDA
27.0523.7712.5611.7111.299.71
EBIT
163.29197.47185.7156.8439.6772.65
EBIT Margin
22.75%26.38%29.71%18.79%16.51%27.24%
Effective Tax Rate
18.88%20.15%20.07%20.56%19.09%20.45%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.